KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Equity Average (2018 - 2025)

Historic Equity Average for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to $464.5 million.

  • Twist Bioscience's Equity Average rose 4.56% to $464.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $464.5 million, marking a year-over-year increase of 4.56%. This contributed to the annual value of $472.8 million for FY2025, which is 1372.79% down from last year.
  • According to the latest figures from Q4 2025, Twist Bioscience's Equity Average is $464.5 million, which was up 4.56% from $475.6 million recorded in Q3 2025.
  • In the past 5 years, Twist Bioscience's Equity Average registered a high of $842.0 million during Q2 2022, and its lowest value of $448.0 million during Q1 2025.
  • For the 5-year period, Twist Bioscience's Equity Average averaged around $607.2 million, with its median value being $605.1 million (2021).
  • As far as peak fluctuations go, Twist Bioscience's Equity Average surged by 24091.78% in 2021, and later crashed by 2475.87% in 2024.
  • Quarter analysis of 5 years shows Twist Bioscience's Equity Average stood at $603.5 million in 2021, then rose by 27.23% to $767.9 million in 2022, then dropped by 20.98% to $606.7 million in 2023, then decreased by 23.47% to $464.3 million in 2024, then rose by 0.05% to $464.5 million in 2025.
  • Its last three reported values are $464.5 million in Q4 2025, $475.6 million for Q3 2025, and $459.2 million during Q2 2025.